EEMY English Greek
 

ΠΡΑΚΤΙΚΕΣ ΚΑΤΕΥΘΥΝΤΗΡΙΕΣ ΟΔΗΓΙΕΣ ΓΙΑ ΤΗΝ ΥΠΕΡΤΑΣΗ - 2008

ΒΙΒΛΙΟΓΡΑΦΙΑ ΠΡΟΗΓΟΥΜΕΝΗ ΣΕΛΙΔΑ  ΠΕΡΙΕΧΟΜΕΝΑ  ΕΠΟΜΕΝΗ ΣΕΛΙΔΑ
  1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-13.
  2. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens 1999, 17(Suppl 2):S7-13.
  3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005, 365:217-23.
  4. Conroy R, Pyorala K, Fitzgerald A, Sans S, Menotti A, De Backer G et al on behalf of the SCORE Project Group. Prediction of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J 2003, 24:987-1003.
  5. Moulopoulos SD, Adamopoulos PN, Diamantopoulos EI, Nanas SN, Anthopoulos LN, IliadiAlexandrou M. Coronary Heart Disease Risk Factors in a Random Sample of Athenian adults. The Athens Study. Am J Epidemiol 1987, 126:882-92.
  6. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD. Prevalence, awareness, treatment, and control of hypertension in Greece. The Didima study. Am J Hypertens 1999, 12:959-65.
  7. Panagiotakos D, Pitsavos C, Chrysohoou C, Skoumas J, Papadimitriou L, Stefanadis C, Toutouzas PK. Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the Attica study. J Hypertens 2003, 21:1483-9.
  8. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004, 33:1345-52.
  9. Sarafidis PA, Lasaridis A, Gousopoulos S, Zebekakis P, Nikolaidis P, Tziolas I, Papoulidou F. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study. J Hum Hypertens 2004, 18:623-9.
  10. Efstratopoulos A, Voyaki S, Baltas A, Vratsistas F, Kirlas D, Kontoyannis J, Sakellariou J, Triantaphyllou G, Alokrios G, Lianas D, Vasilakis E, Fotiadis K, Kastritsea E. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006, 19:53-60.
  11. Μουντοκαλάκης Θ, Αχείμαστος Α, Βαρσαμής Ε, Ζαμπούλης Χ, Καρατζάς Ν, Παπαδογιάννης Δ, Στεργίου Γ. Συστάσεις για τη διάγνωση και τη θεραπεία της υπέρτασης από τον κλινικό γιατρό. Πρόγραμμα "Υγεία για τον Πολίτη". Οδηγίες Ορθής Κλινικής Πράξης και Φαρμακοθεραπείας. Υπουργείο Υγείας και Πρόνοιας, 2000.
  12. Στεργίου Γ, Αχείμαστος Α, Βαρσαμής Ε, Βλαχάκος Δ, Ελισάφ Μ, Καρατζάς Ν, Μουντοκαλάκης Θ, Παπαδογιάννης Δ, Σιαμόπουλος Κ. Πρακτικές Κατευθυντήριες Οδηγίες για την Υπέρταση 2005. Ελληνική Εταιρεία Μελέτης της Υπέρτασης. Αρχεία Ελληνικής Ιατρικής 2005, 22:10-22.
  13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003, 289:2560-72.
  14. NICE clinical guideline 34. Hypertension: management of hypertension in adults in primary care (partial update of NICE clinical guideline 18). London: National Institute for Health and Clinical Excellence; 2006. www.nice.org.uk/CG018.
  15. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-87.
  16. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, et al. Treatment of hypertension in the prevention and management of i schemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007, 115:2761-88.
  17. World Health Organization. Guidelines for assessment and management of cardiovascular risk 2007. www.ish-world.com/default.aspx? Guidelines.
  18. Ruilope L, Kjeldsen S, de la Sierra A, Mancia G, Ruggenenti P, Stergiou G, Bakris GL, Giles TD. The kidney and cardiovascular risk. Implications for management: a consensus statement from the European Society of Hypertension. Blood Press 2007, 16:72-9.
  19. The Fourth Report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. National High Blood Pressure Education Program Working Group on high blood pressure in children and adolescents. Pediatrics 2004, 114:555-76
  20. Stergiou GS, Salgami E. New European, American and International guidelines for hypertension management: agreement and disagreement. Exp Rev Cardiovasc Ther 2004, 2:359-68
  21. Stergiou G, Mengden T, Padfield P, Parati G, O'Brien E on behalf of the European Society Of Hypertension Working Group on Blood Pressure Monitoring. Self-blood pressure monitoring at home i s an i mportant adjunct to clinic measurements in patients with hypertension. Br Med J 2004, 329:870-1.
  22. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension Recommendations for Conventional, Ambulatory and Home Blood Pressure Measurement. J Hypertens 2003, 21:821-48.
  23. Pickering T, Hall J, Appel L, Falkner B, Graves J, Hill M, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45:142-61.
  24. Μουντοκαλάκης Θ. Ιατρική βασισμένη σε ενδείξεις και η ελευθερία του γιατρού. Ιατρική 1998, 73:111-3.
  25. Staessen J, Wang J, Thijs L. Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001, 358:1305-15
  26. Blood Pressure Lowering Treatment Trialists. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-35.
  27. Blood Pressure Lowering Treatment Trialists' Collaboration. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007, 25:951-8.
ΠΡΟΗΓΟΥΜΕΝΗ ΣΕΛΙΔΑ  ΠΕΡΙΕΧΟΜΕΝΑ  ΕΠΟΜΕΝΗ ΣΕΛΙΔΑ